A detailed history of Virtus ETF Advisers LLC transactions in Geron Corp stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 67,490 shares of GERN stock, worth $274,684. This represents 0.15% of its overall portfolio holdings.

Number of Shares
67,490
Previous 67,490 -0.0%
Holding current value
$274,684
Previous $286,000 6.99%
% of portfolio
0.15%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $87,683 - $143,970
28,285 Added 72.15%
67,490 $286,000
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $4,702 - $9,243
-2,687 Reduced 6.41%
39,205 $129,000
Q4 2023

Feb 15, 2024

BUY
$1.74 - $2.31 $17,203 - $22,838
9,887 Added 30.89%
41,892 $88,000
Q3 2023

Nov 07, 2023

SELL
$2.11 - $3.28 $6,720 - $10,446
-3,185 Reduced 9.05%
32,005 $67,000
Q2 2023

Aug 14, 2023

SELL
$1.97 - $3.69 $15,486 - $29,007
-7,861 Reduced 18.26%
35,190 $112,000
Q1 2023

May 15, 2023

SELL
$2.14 - $3.4 $35,423 - $56,280
-16,553 Reduced 27.77%
43,051 $93,000
Q4 2022

Feb 14, 2023

SELL
$2.03 - $2.42 $44,678 - $53,261
-22,009 Reduced 26.97%
59,604 $144,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $996 - $1,755
597 Added 0.74%
81,613 $191,000
Q2 2022

Aug 12, 2022

SELL
$1.19 - $1.65 $47,751 - $66,209
-40,127 Reduced 33.12%
81,016 $126,000
Q1 2022

May 16, 2022

SELL
$0.99 - $1.6 $7,110 - $11,491
-7,182 Reduced 5.6%
121,143 $165,000
Q4 2021

Feb 14, 2022

SELL
$1.22 - $1.72 $22,317 - $31,463
-18,293 Reduced 12.48%
128,325 $157,000
Q3 2021

Nov 15, 2021

SELL
$1.2 - $1.5 $9,178 - $11,473
-7,649 Reduced 4.96%
146,618 $201,000
Q2 2021

Aug 10, 2021

SELL
$1.25 - $1.83 $22,905 - $33,532
-18,324 Reduced 10.62%
154,267 $218,000
Q1 2021

May 17, 2021

BUY
$1.52 - $2.1 $4,626 - $6,392
3,044 Added 1.8%
172,591 $273,000
Q4 2020

Feb 12, 2021

SELL
$1.55 - $2.05 $32,109 - $42,467
-20,716 Reduced 10.89%
169,547 $270,000
Q3 2020

Nov 13, 2020

SELL
$1.59 - $2.19 $41,238 - $56,799
-25,936 Reduced 12.0%
190,263 $331,000
Q2 2020

Aug 05, 2020

SELL
$1.05 - $2.18 $24,673 - $51,227
-23,499 Reduced 9.8%
216,199 $471,000
Q1 2020

May 14, 2020

SELL
$0.89 - $1.49 $31,114 - $52,090
-34,960 Reduced 12.73%
239,698 $285,000
Q4 2019

Feb 13, 2020

BUY
$1.27 - $1.54 $133,465 - $161,840
105,091 Added 61.98%
274,658 $374,000
Q3 2019

Nov 12, 2019

SELL
$1.15 - $1.59 $10,861 - $15,017
-9,445 Reduced 5.28%
169,567 $226,000
Q2 2019

Aug 13, 2019

BUY
$1.37 - $2.02 $245,246 - $361,604
179,012 New
179,012 $252,000
Q1 2019

May 14, 2019

SELL
$1.01 - $1.83 $218,407 - $395,728
-216,245 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$0.98 - $1.85 $93,001 - $175,563
94,899 Added 78.21%
216,245 $216,000
Q3 2018

Nov 14, 2018

SELL
$1.76 - $6.38 $152,674 - $553,445
-86,747 Reduced 41.69%
121,346 $214,000
Q2 2018

Aug 10, 2018

SELL
$3.29 - $4.82 $563,698 - $825,844
-171,337 Reduced 45.16%
208,093 $714,000
Q1 2018

May 14, 2018

BUY
$1.81 - $5.98 $370,592 - $1.22 Million
204,747 Added 117.21%
379,430 $1.61 Million
Q4 2017

Feb 14, 2018

BUY
$1.8 - $2.32 $88,664 - $114,278
49,258 Added 39.27%
174,683 $314,000
Q3 2017

Nov 14, 2017

BUY
$1.99 - $2.65 $22,831 - $30,403
11,473 Added 10.07%
125,425 $273,000
Q2 2017

Aug 14, 2017

BUY
N/A
113,952
113,952 $316,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.54B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.